Known targets — ChEMBL curated mechanism
AGTR1DHFRGABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTNR3C2PBP2XPTGS1PTGS2VKORC1blablaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAftsImrcAmrcBmrdApbp1apbp1bpbp2apbp2bpbp3polthyA
The experimentally established mechanism targets of Potassium Ion. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Lithium Ion SCHEMBL31393245 | 0.94 | — | — | |
| Choline SCHEMBL28645441 | 0.76 | MEN1 (0.44) | — | |
| Potassium Ion SCHEMBL29222737 | 0.76 | CA4 (0.40) | — | |
| Potassium Ion SCHEMBL11546232 | 0.74 | TGFBR1 (0.36) | — | |
| SCHEMBL3310419 | 0.71 | CA2 (0.41) | — | |
| SCHEMBL208791 | 0.69 | — | — | |
| SCHEMBL177789 | 0.69 | — | — | |
| SCHEMBL208469 | 0.69 | GRIA1 (0.37) | — | |
| Potassium Ion SCHEMBL28470476 | 0.67 | — | — | |
| SCHEMBL28781877 | 0.67 | DHFR (0.33) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 253 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122074579-A | Ginseng adventitious root pressed candy and preparation method thereof | — | 2026-05-26 | — | — | CN | claimed |
| EP-4611765-A2 | FAST-DISSOLVING DOSAGE FORMS AND USES THEREOF | Astrocyte Pharmaceuticals, Inc. (US) | 2025-09-10 | — | — | EP | claimed |
| CN-118845681-A | Amlodipine besylate orally disintegrating tablet composition and preparation method thereof | 广东万泰科创药业有限公司 | 2024-10-29 | — | — | CN | claimed |
| WO-2024144874-A2 | FAST-DISSOLVING DOSAGE FORMS AND USES THEREOF | ASTROCYTE PHARMACEUTICALS, INC. (US) | 2024-07-04 | — | — | WO | claimed |
| CN-116998647-A | Plant beverage and preparation method thereof | 梁和标 | 2023-11-07 | — | — | CN | claimed |
| WO-2023114529-A2 | PHARMACOACTIVE FORMULATIONS FOR DELIVERY OF PSYCHEDELIC COMPOUNDS | BENNES, INC. (US) | 2023-06-22 | — | — | WO | claimed |
| CN-115803020-A | Orally disintegrating tablet containing milobalin besylate | 第一三共株式会社 | 2023-03-14 | — | — | CN | claimed |
| CN-115584146-A | Modified calcium carbonate and preparation method thereof | 湖南磊鑫新材料科技有限公司 | 2023-01-10 | — | — | CN | claimed |
| CN-115251397-A | Stable milky mineral supplement | 南京北极光生物科技有限公司 | 2022-11-01 | — | — | CN | claimed |
| EP-2421504-B2 | PAEDIATRIC SOLUTIONS COMPRISING PROPRANOLOL | PIERRE FABRE DERMATOLOGIE (FR) | 2022-08-10 | — | — | EP | claimed |
| EP-3384899-A1 | PAEDIATRIC SOLUTIONS COMPRISING A BETA-BLOCKER | Pierre Fabre Dermatologie (FR) | 2018-10-10 | — | — | EP | claimed |
| EP-2497461-B1 | Paediatric solutions comprising a beta-blocker | PIERRE FABRE DERMATOLOGIE (FR) | 2018-06-20 | — | — | EP | claimed |
| WO-2018089863-A1 | FORMULATIONS FOR EFFICIENT DELIVERY OF CANNABINOIDS | BENNES, INC. (US) | 2018-05-17 | — | — | WO | claimed |
| EP-2421504-B1 | PAEDIATRIC SOLUTIONS COMPRISING PROPRANOLOL | PIERRE FABRE DERMATOLOGIE (FR) | 2017-03-08 | — | — | EP | claimed |
| US-20150087719-A1 | PAEDIATRIC SOLUTIONS COMPRISING A BETA-BLOCKER | FABRE PIERRE DERMO COSMETIQUE (FR) | 2015-03-26 | — | — | US | claimed |
| EP-2497461-A2 | Paediatric solutions comprising a beta-blocker | Pierre Fabre Dermo-Cosmétique (FR) | 2012-09-12 | — | — | EP | claimed |
| EP-2421504-A1 | PAEDIATRIC SOLUTIONS COMPRISING A BETA-BLOCKER | Pierre Fabre Dermo-Cosmétique (FR) | 2012-02-29 | — | — | EP | claimed |
| US-20120035270-A1 | PAEDIATRIC SOLUTIONS COMPRISING A BETA-BLOCKER | PIERRE FABRE DERMATOLOGIE (FR) | 2012-02-09 | — | — | US | claimed |
| EP-2246044-A1 | Paediatric solutions comprising a beta-blocker | Pierre Fabre Dermo-Cosmétique (FR) | 2010-11-03 | — | — | EP | claimed |
| WO-2010122442-A1 | PAEDIATRIC SOLUTIONS COMPRISING A BETA-BLOCKER | PIERRE FABRE DERMO-COSMETIQUE (FR) | 2010-10-28 | — | — | WO | claimed |